Functional study of the bladder mechanosensitive afferent pathways
Functional study of the bladder mechanosensitive afferent pathways
批准号:
23791743
负责人:
AIZAWA Naoki
金额:
$2.25万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have established the measurement of single-unit afferent activities (SAAs) of the bladder mechanosensitive primary afferent nerve fibers in in vivo rats, and have investigated the effect of several drugs on these SAAs in this experimental set-up. The study demonstrated that L-arginine (an NO substrate), tadalafil and sildenafil (PDE5 inhibitors), and mirabegron (a β3-adrenoceptor (β3-AR) agonist), can inhibit both Aδ- and C- mechanosensitive afferent fiberst. Moreover, the activation of TRPV4 in the bladder, probably urothelium, facilitated the micturition reflex by P2X-purinoceptor-mediated activation of the mechanosensitive capsaicin-insensitive C-fibers. In addition, L-arginine and tadalafil can inhibit the activation of both fibers induced by intravesical acrolein, a metabolite of cyclophosphamide. We further investigated the relationship between the SAAs and bladder microcontractions, which have been recognized of myogenic origin. The results showed that mirabegron inhibited both bladder microcontractions and Aδ-fiber afferent activity, suggesting that the microcontractions may be linked to the mechanosensitive afferent activities of Aδ-fibers. In another study, we have established the measurement of SAAs synchronized with rhythmic bladder contractions. We found that mechanosensitive afferent activities of both Aδ- and C- fibers of the rat bladder are capable of being responsive to both stretch and contractile stimuli, and. that L-arginine and mirabegron inhibit the activation of mechanosensitive afferent nerves induced by bladder contractions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Effects of silodosin, a selective α1A-adrenoceptor antagonist, on the single primary bladder afferent activity of the rat
选择性α1A肾上腺素受体拮抗剂西洛多辛对大鼠单一初级膀胱传入活动的影响
DOI:
--
发表时间:
2013
期刊:
影响因子:
--
作者:
[Igawa Y, Kumano S, Aizawa N, Ito H, Sugiyama R, Homma Y, Igawa Y, Igawa Y, Igawa Y, Igawa Y, Aizawa N,Homma Y,Igawa Y]
通讯作者:
Aizawa N,Homma Y,Igawa Y
Wyndaele JJ.Effects of nitric oxide on the primary bladder afferent activities of the rat with and without intravesical acrolein treatment
Wyndaele JJ.一氧化氮对有或没有膀胱内丙烯醛治疗的大鼠初级膀胱传入活动的影响
DOI:
--
发表时间:
2011
期刊:
Eur Urol
影响因子:
23.4
作者:
[Aizawa N, Igawa Y, Nishizawa O]
通讯作者:
Nishizawa O
Comparison of the Effects of Mirabegron, a Novel Β3-Adrenoceptor Agonist, With the Anticholinergic Agent, Oxybutynin, on Primary Bladder Afferent Activity and Bladder Microcontractions in Rats
新型β3-肾上腺素受体激动剂米拉贝隆与抗胆碱能药物奥昔布宁对大鼠初级膀胱传入活动和膀胱微收缩的影响比较
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Aizawa N, Homma Y, Igawa Y]
通讯作者:
Igawa Y
A Novel Beta3-Adorenoceptor Agonist,on the Primary Bladder Afferent Activity of the Rat
新型β3-肾上腺素受体激动剂对大鼠初级膀胱传入活动的影响
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Aizawa N, Homma Y, Igawa YEffects of Mirabegron]
通讯作者:
Igawa YEffects of Mirabegron
Goto-Kakizaki糖尿病モデルラットにおける下部尿路機能障害の病態解析
Goto-Kakizaki糖尿病模型大鼠下尿路功能障碍的病理分析
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[相澤直樹, 本間之夫, 井川靖彦]
通讯作者:
井川靖彦
共 27 条
Interpretation bias which enhance and maintain Taijin-Kyofusho (social anxiety disorder): A developmental study
-
批准号:24530867
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2012
-
负责人:AIZAWA Naoki
-
依托单位:
Voices and Texts in Modern Europe
-
批准号:21520311
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2009
-
负责人:AIZAWA Naoki
-
依托单位:
A basic study on cognitive brain function in projective methods : Examination of prefrontal hemodynamic changes using NIRS
-
批准号:21530726
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2009
-
负责人:AIZAWA Naoki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于“人源化”新型近红外荧光探针的构建及其在膀胱癌诊疗一体化中的应用研究
-
批准号:2026JJ50315
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨勇军
-
依托单位:
ALKBH5 通过表观调控抑制膀胱癌转移的机 制研究及类器官辅助精准治疗策略
-
批准号:JCZRLH202601789
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
AKAP95通过调控嘌呤代谢通路抑制膀胱癌发生发展的机制及功能研究
-
批准号:JCZRLH202601820
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RPS27a类泛素化修饰GOLPH3诱导高尔基体自噬介导Apelin-13促人膀胱癌细胞的增殖和迁移
-
批准号:2026JJ80179
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘世敏
-
依托单位:
功能化纳米佐剂的制备及其用于膀胱癌放疗增敏的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:熊伟
-
依托单位:
基于尿路上皮机械敏感通道 TRPV1、TRPV4 探讨“益火补土”针法治疗膀胱过度活动症的机制研究
-
批准号:2026JJ82592
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邬婉蓉
-
依托单位:
基于SPI1-CRYAB-NF-κB轴调控铁死亡与免疫逃逸的膀胱癌机制研究
-
批准号:2026JJ82055
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈昊
-
依托单位:
SMYD2通过上调PYCR1表达调控PINK1/Parkin线粒体自噬通路促进膀胱癌进展的机制研究
-
批准号:2026JJ82057
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈俊杰
-
依托单位:
宫颈癌根治术后神经源性膀胱症状群轨迹及干预研究
-
批准号:2026JJ82064
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张岸辉
-
依托单位:
下调的KDM6A通过调节上皮间质转化促进膀胱癌的侵袭及免疫逃逸
-
批准号:2026JJ80593
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈星星
-
依托单位: